CAPELLO JEFFREY D — SEC insider filings

SEC reporting owner CIK 1224108. 19 insider filings on record with FilingPulse; latest filed 2026-10-30.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2022-10-11 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEOGEN CORP (NEOG)Director121 leg · 20,712 sh · $100,217—22
AGIOS PHARMACEUTICALS, INC. (AGIO)Director7——18

Insider filings — CAPELLO JEFFREY D

FiledFormIssuerReported transactionsSource
2026-10-304NEOGEN CORP (NEOG)Option exercise (M): 1,776 @ $12.21 · Option exercise (M): 1,776 (derivative) @ $12.21EDGAR
2026-10-024NEOGEN CORP (NEOG)Grant/award (A): 9,804 @ $12.24 · Grant/award (A): 20,558 (derivative) @ $0EDGAR
2026-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0EDGAR
2026-06-164AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0EDGAR
2025-10-294NEOGEN CORP (NEOG)Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19EDGAR
2025-10-284NEOGEN CORP (NEOG)Option exercise (M): 2,025 @ $6.19 · Option exercise (M): 2,025 (derivative) @ $6.19EDGAR
2025-10-274NEOGEN CORP (NEOG)Grant/award (A): 19,769 @ $6.07 · Grant/award (A): 50,814 (derivative) @ $0EDGAR
2025-10-094NEOGEN CORP (NEOG)Option exercise (M): 2,071 @ $5.63 · Option exercise (M): 2,071 (derivative) @ $5.63EDGAR
2025-06-234AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,861 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0EDGAR
2025-06-174AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,977 @ $0 · Option exercise (M): 1,977 (derivative) @ $0EDGAR
2025-04-224NEOGEN CORP (NEOG)Purchase (P): 20,712 @ $4.84EDGAR
2024-10-294NEOGEN CORP (NEOG)Option exercise (M): 1,776 @ $13.81 · Option exercise (M): 1,776 (derivative) @ $13.81EDGAR
2024-10-284NEOGEN CORP (NEOG)Grant/award (A): 6,075 @ $13.58 · Grant/award (A): 18,653 (derivative) @ $0EDGAR
2024-10-094NEOGEN CORP (NEOG)Option exercise (M): 2,070 @ $15.07 · Option exercise (M): 2,070 (derivative) @ $15.07EDGAR
2024-06-244AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0EDGAR
2024-06-174AGIOS PHARMACEUTICALS, INC. (AGIO)Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0EDGAR
2023-10-314NEOGEN CORP (NEOG)Option exercise (M): 13,716 (derivative) @ $0 · Option exercise (M): 5,329 (derivative) @ $0EDGAR
2023-06-154AGIOS PHARMACEUTICALS, INC. (AGIO)Grant/award (A): 5,929 (derivative) @ $0 · Grant/award (A): 33,177 (derivative) @ $0EDGAR
2022-10-114NEOGEN CORP (NEOG)Option exercise (M): 18,416 (derivative) @ $0 · Option exercise (M): 6,212 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-08-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1224108 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs